Navigation Links
When Her Lot is maligned by HER-2, Staying Abreast is Imperative

HER 2 is out of the closet, as a virulent breast cancer strain that can be won over only with awareness, timely detection, and early treatment//. Among the many types of breast cancer, HER2, an aggressive type of breast cancer is detected in almost one in 5 women.

HER2, which represents the human epidermal growth factor receptor 2, is a protein manufactured by a particular gene that takes care of cell growth, division and repair. HER2 positive women portray excessive quantities of HER2 in the breast cells.

Breast cancer is becoming one of the leading causes of death amongst women in the 35 to 55 age group. Armed with statistics, The International Agency for Research on Cancer has said that in 2001 nearly 79,000 women were affected by breast cancer, which further increased to about 80,000 in 2002. In India, the urban areas are portraying a higher incidence of breast cancer compared to the rural areas.

What makes HER 2 dangerous and challenging is that the tumors progress at a very rapid rate. The chance of a relapse of the tumor is also very high, enhancing the risk of the disease spreading to all parts of the body. What makes it worse, in comparison to other types of cancers is that HER 2 positive can simply cut the life expectancy by 50%.

Herceptin is turning out to be the proven method to bell this virulent breast cancer strain. This magic treatment targets the cancerous cells and effectively hampers their growth. The good thing is that Herceptin does not touch the healthy cells and patients may not experience all of the usual side effects like hair loss, fatigue, nausea, loss of appetite, or a reduction in red or white blood cell count.

All this will work provided the disease is detected early and the treatment has begun at the opportune time. This is perhaps the only method to arrest the advancement of the disease as well as realize positive treatment outcomes.
'"/>




Page: 1

Related medicine news :

1. Staying mentally energitic prevents Alzheimers
2. Staying agile reduces hip fracture risk
3. Staying Awake With Coffee
4. Staying Indoors Responsible for 1995 Heat Wave Killings
5. Is There Any Clinical Benefit to Staying on a Failing Regimen?
6. Concerted Effort Imperative For Elimination Of Tropical Diseases: WHO
7. Community Awareness Is Imperative For Eradication Of Rabies
8. Imperative to Extend Reach of Federal Health Insurance Schemes for children
9. Additional Research Imperative on Lung Cancer in Women
10. Preventive Ill-Health Plan Imperative to NHS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: